OBERWEIS ASSET MANAGEMENT INC/
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 937886
LISLE, IL
Position in INDV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,916,028
New position
Shares Held
653,413
first reported quarter
Ownership
0.536%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026OBERWEIS ASSET MANAGEMENT INC/ holds $92,494,217 across 6 Drug Manufacturers - Specialty & Generic names. INDV ranks #1 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
653,413 | $19,916,028 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
221,386 | $17,024,583 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
318,634 | $15,342,227 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
277,100 | $15,326,401 | |
| 5 | LQDA |
Liquidia Corp
|
372,100 | $14,043,054 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
439,300 | $10,841,924 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,916,028 | 653,413 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||